CSBR:NASDAQ
Champions Oncology Inc
4,34 USD
arrow_downward
−1,36%(−0,060) 1 D
20. nov., 16:00:00 GMT-5 · USD
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for CSBR …
Åpne
4,45 USD
Høy
4,45 USD
Lav
4,34 USD
Markedsverdi
60,41 mill.
Snittvolum
6,97k
Volum
8,94k
52 u høy
8,31 USD
52 u lav
4,34 USD
EPS
−0,08 USD
Beta
0,47
Utestående aksjer
13,92 mill.
Antall ansatte
217
Åpne
4,45 USD
Høy
4,45 USD
Lav
4,34 USD
Markedsverdi
60,41 mill.
Snittvolum
6,97k
Volum
8,94k
52 u høy
8,31 USD
52 u lav
4,34 USD
EPS
−0,08 USD
Beta
0,47
Utestående aksjer
13,92 mill.
Antall ansatte
217
Nyhetssaker
Fra nettkilder og nyhetspartnere
AP News
·
for 17 minutter siden
S&P 500 sinks 3.7% and Nasdaq composite goes negative for the year as tech sell-off worsens
WSJ
·
for 12 timer siden
S&P 500 Flirts With Correction
Los Angeles Times
·
for 5 timer siden
S&P 500 falls 10% from record, entering correction as AI trade unravels
Honolulu Star-Advertiser
·
for 57 minutter siden
Wall Street rout pushes S&P 500, Dow into correction
Profil
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
Om Champions Oncology Inc
Administrerende direktør-
Ansatte217
Grunnlagt2007
HovedkontorHackensack, New Jersey, USA
SektorHealth Care
Bransje-
Nettstedchampionsoncology.com